Digital health technologies in clinical trials are no longer “nice to have”; they are becoming a core operating capability for participant-centered execution, decentralized elements, and faster, higher-quality data flow. This article explains which technologies matter most, how regulators frame expectations, and how to govern interoperability, data integrity, and AI responsibly.